MARLBOROUGH, Mass.,
Nov. 8, 2021 /PRNewswire/
-- Boston Scientific Corporation (NYSE: BSX) will participate
in two upcoming investor conferences.
On November 15, 2021, Dan Brennan, executive vice president and chief
financial officer, and Lauren
Tengler, vice president, Investor Relations, will
participate in a 30-minute question-and-answer session with the
host analyst at the virtual 2021 Stifel Healthcare Conference. The
session will begin at approximately 8:00
a.m. EST.
On December 1, 2021, Dave Pierce, executive vice president and
president, MedSurg & Endoscopy; Dr. Brian Dunkin, chief medical officer, Endoscopy;
and Lauren Tengler will participate
in a 45-minute question-and-answer session with the host analyst
for the 2021 virtual Evercore ISI HealthCONx Conference. The
session will begin at approximately 8:00
a.m. EST.
A live webcast and replay of the webcast for each event will be
accessible at investors.bostonscientific.com. The replay will be
available approximately one hour following the completion of each
event.
About Boston Scientific
Boston Scientific transforms
lives through innovative medical solutions that improve the health
of patients around the world. As a global medical technology
leader for 40 years, we advance science for life by providing a
broad range of high performance solutions that address unmet
patient needs and reduce the cost of healthcare. For more
information, visit www.bostonscientific.com and connect on Twitter
and Facebook.
CONTACTS
|
|
Media:
|
Investors:
|
Kate
Haranis
|
Lauren
Tengler
|
508-683-6585
(office)
|
508-683-4479
(office)
|
Media
Relations
|
Investor
Relations
|
Boston Scientific
Corporation
|
Boston Scientific
Corporation
|
Kate.Haranis@bsci.com
|
BSXInvestorRelations@bsci.com
|
View original content to download
multimedia:https://www.prnewswire.com/news-releases/boston-scientific-announces-upcoming-conference-schedule-301417595.html
SOURCE Boston Scientific Corporation